Cisplatin (Cis-DDP) is one of the most widely used anti-cancer drugs. It is applicable to many types of cancer, including lung, bladder, and breast cancer. However, its use is now limited because of drug resistance. p90 ribosomal S6 kinase (p90RSK) is one of the downstream effectors in the extracellular signalregulated protein kinases 1 and 2 (ERK1/2) pathway and high expression of p90RSK is observed in human breast cancer tissues. Therefore, we investigated the role of p90RSK in the Cis-DDP resistance-related signaling pathway and epithelialmesenchymal transition (EMT) in breast cancer cells. First, we discovered that MDA-MB-231 cells exhibited more Cis-DDP resistance than other breast cancer cells, including MCF-7 and BT549 cells. Cis-DDP increased p90RSK activation, whereas the inactivation of p90RSK using a small interfering RNA (siRNA) or dominant-negative kinase mutant plasmid overexpression significantly reduced Cis-DDP-induced cell proliferation and migration via the inhibition of matrix metallopeptidase (MMP)2 and MMP9 in MDA-MB-231 cells. In addition, p90RSK activation was involved in EMT via the upregulation of mRNA expression, including that of Snail, Twist, ZEB1, N-cadherin, and vimentin. We also investigated NF-κB, the upstream regulator of EMT markers, and discovered that Cis-DDP treatment led to NF-κB translocation in the nucleus as well as its promoter activity. Our results suggest that targeting p90RSK would be a good strategy to increase Cis-DDP sensitivity in triple-negative breast cancers. [BMB Reports 2019; 52(12): 706-711].
Conflict of interest statement
The authors have no conflicting interests.
Long non-coding RNA H19 mediates ovarian cancer cell cisplatin-resistance and migration during EMT.Int J Clin Exp Pathol. 2019 Jul 1;12(7):2506-2515. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31934077 Free PMC article.
miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.Oncotarget. 2016 Apr 26;7(17):24510-26. doi: 10.18632/oncotarget.8229. Oncotarget. 2016. PMID: 27014910 Free PMC article.
Enterolactone modulates the ERK/NF-κB/Snail signaling pathway in triple-negative breast cancer cell line MDA-MB-231 to revert the TGF-β-induced epithelial-mesenchymal transition.Cancer Biol Med. 2018 May;15(2):137-156. doi: 10.20892/j.issn.2095-3941.2018.0012. Cancer Biol Med. 2018. PMID: 29951338 Free PMC article.
Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells.Acta Pharmacol Sin. 2016 Dec;37(12):1606-1622. doi: 10.1038/aps.2016.93. Epub 2016 Nov 14. Acta Pharmacol Sin. 2016. PMID: 27840408 Free PMC article.
Inhibition of p90 ribosomal S6 kinase attenuates cell migration and proliferation of the human lung adenocarcinoma through phospho-GSK-3β and osteopontin.Mol Cell Biochem. 2016 Jul;418(1-2):21-9. doi: 10.1007/s11010-016-2727-9. Epub 2016 May 28. Mol Cell Biochem. 2016. PMID: 27236820